Moss Adams Wealth Advisors LLC Gilead Sciences, Inc. Transaction History
Moss Adams Wealth Advisors LLC
- $946 Billion
- Q4 2024
A detailed history of Moss Adams Wealth Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moss Adams Wealth Advisors LLC holds 3,114 shares of GILD stock, worth $302,680. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,114
Previous 2,559
21.69%
Holding current value
$302,680
Previous $215 Million
34.07%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
1,963Shares Held
995MCall Options Held
10.5MPut Options Held
9.86M-
Black Rock Inc. New York, NY121MShares$11.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.2 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.44 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$6.01 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.85 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $122B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...